Nuclear Receptor Related 1 (NURR1)

📖 Wiki Page

protein614 wordssynced 2026-04-02

Overview

...

Overview

Mermaid diagram (expand to render)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Nuclear Receptor Related 1 (NURR1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NURR1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nuclear Receptor Related 1 (NURR1)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NURR1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">66 edges</a></td>
</tr>
</table>

Nuclear Receptor Related 1 is a protein that nurr1 is an orphan nuclear receptor with ligand-independent activity:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@zetterstrm1996]

[@yang2021]

Structure

NURR1 is a member of the nuclear receptor superfamily:

N-terminal AF-1 domain: Constitutive transcriptional activation
DNA-binding domain (DBD): Two C4-type zinc fingers
Hinge region: Flexible linker between DBD and LBD
Ligand-binding domain (LBD): Responsible for dimerization and cofactor binding
C-terminal AF-2 domain: Ligand-dependent activation function

NURR1 binds DNA as a monomer or dimer and regulates gene expression without classical ligand activation.

Normal Function

NURR1 is an orphan nuclear receptor with ligand-independent activity:

Dopaminergic System Development

Midbrain development: Essential for development of dopaminergic [neurons](/entities/neurons)
DA neuron maintenance: Maintains dopaminergic neuron identity and function
Tyrosine hydroxylase regulation: Directly activates TH and AADC expression
Survival factors: Promotes expression of neurotrophic factors

Gene Regulation

Transcriptional activator: Binds NGFI-B response elements (NBRE)
Retrotransposon suppression: Represses LINE-1 retrotransposons in neurons
Anti-inflammatory: Represses inflammatory gene expression

Cellular Homeostasis

Metabolic regulation: Affects glucose and lipid metabolism
Cell cycle: Modulates cell proliferation and differentiation
Neuroprotection: Promotes neuronal survival

Role in Neurodegeneration

Parkinson's Disease

NURR1 is critical in PD pathogenesis:

Dopaminergic neuron loss: Reduced NURR1 contributes to SNc degeneration
Gene mutations: NR4A2 mutations cause familial PD
Therapeutic target: NURR1 agonists being developed
Transcription dysregulation: Alters expression of DA-specific genes

Amyotrophic Lateral Sclerosis

Motoneuron maintenance: Important for spinal cord motoneuron survival
Gene expression: Alters expression in ALS models
Therapeutic potential: NURR1 activation may protect motoneurons

Huntington's Disease

Striatal neuron survival: Protects medium spiny neurons
Transcription regulation: Corrects dysregulated gene expression
Neuroprotection: NURR1 overexpression improves phenotype

Alzheimer's Disease

Cognitive function: Associated with learning and memory
Neuroinflammation: Modulates inflammatory responses
Therapeutic potential: Being investigated for AD treatment

Therapeutic Targeting

NURR1 agonists: Cytosporone B and synthetic analogs
Gene therapy: AAV-mediated NURR1 expression
Epigenetic modulators: [HDAC](/entities/hdac-enzymes) inhibitors increase NURR1 expression
Combination approaches: NURR1 + BDNF co-therapy

Key Publications

[Zetterstrom et al., Nurr1 is essential for the development of midbrain dopaminergic neurons (1996)](https://doi.org/10.1126/science.274.5289.969)

[Le et al., Mutations in NR4A2 cause familial Parkinson's disease (2003)](https://doi.org/10.1038/nn1059)

[Jankovic et al., Nurr1 in Parkinson's disease: Therapeutic potential (2015)](https://doi.org/10.1016/j.neuropharm.2014.11.019)

[Kim et al., NURR1 and retinoic acid receptor signaling in neurodegeneration (2020)](https://doi.org/10.1016/j.tins.2020.01.008)

[Zhang et al., NURR1: A potential therapeutic target for neurodegenerative diseases (2022)](https://doi.org/10.1016/j.pharmthera.2022.108178)

External Links

[UniProt P43354](https://www.uniprot.org/uniprot/P43354)
[NIH Genetic Testing Registry - NR4A2](https://www.ncbi.nlm.nih.gov/gtr/genes/7979/)
[Human Protein Atlas - NURR1](https://www.proteinatlas.org/ENSG00000153234-NR4A2)
[OMIM 601828 - NR4A2-related Parkinsonism](https://www.omim.org/entry/601828)

References

[Zetterström et al., Nurr1 is essential for the development of midbrain dopaminergic neurons (1996) (1996)](https://pubmed.ncbi.nlm.nih.gov/8744353/)

[Le et al., Mutations in NR4A2 cause familial Parkinson's disease (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/14570705/)

[Jankovic et al., Nurr1 in Parkinson's disease: Therapeutic potential (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25556531/)

[Kim et al., NURR1 and retinoic acid receptor signaling in neurodegeneration (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32043751/)

[Zhang et al., NURR1: A potential therapeutic target for neurodegenerative diseases (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35271719/)

[Li et al., Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/36555826/)

[Chen et al., Nurr1-Based Therapies for Parkinson's Disease (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27012974/)

[Liu et al., The role of NURR1 in metabolic abnormalities of Parkinson's disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35761385/)

[Wang et al., Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease (2024) (2024)](https://pubmed.ncbi.nlm.nih.gov/40267723/)

[Yang et al., Nurr1 repression mediates cardinal features of Parkinson's disease in alpha-synuclein transgenic mice (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33902111/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Programmable Neuronal Circuit Repair via Epigenetic CRISPR](/hypothesis/h-9d22b570) — <span style="color:#ffd54f;font-weight:600">0.45</span> · Target: NURR1, PITX3, neuronal identity transcription factors

Pathway Diagram

The following diagram shows the key molecular relationships involving Nuclear Receptor Related 1 (NURR1) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Nuclear Receptor Related 1 (NURR1)